Allogene Therapeutics Inc (ALLO)
Cost of Revenue
$0.00
TTM · Period ending: · USD
ALLO Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
ALLO TTM Cost of Revenue ($0.00 → $0.00)
TTM cost of revenue
High-resolution chart · PNG
ALLO cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 3,555,000 | |
| 3,555,000 | |
| 7,127,000 | |
| 7,127,000 | |
| 3,572,000 | |
| 3,572,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |